RENAL VASCULARISATION CAUSING END - STAGE FAILURES AND OUTCOMES: A POOLED ANALYSIS OF COMMUNITY BASED STUDIES
Abstract
Although acute renal failure (ARF) is believed to be common in the setting of critical illness and is associated with a high risk of death, little is known about its epidemiology and outcome or how these vary in different regions of the world. Prospective observational study of ICU patients who either were treated with renal replacement therapy (RRT) or fulfilled at least one of the predefined criteria for ARF. The main outcomes are occurrence of ARF, factors contributing to etiologic, illness severity, treatment and need for renal support after hospital discharge and hospital mortality. The marginal effects of acute kidney injury on in-hospital mortality, length of stay (LOS) and costs have not been well described. The acute kidney injury is associated with significantly increased mortality, LOS, and costs across a broad spectrum of conditions. Moreover, outcomes are related directly to the severity of acute kidney injury, whether characterized by nominal or percentage changes in serum creatinine. Individuals should check with a doctor that an exercise program is suited to their age, weight and health. Including abusing alcohol and drugs.
Keywords:
Acute renal failure, Replacement therapy, Glomerular filtration rate, ambulatory peritoneal dialysis.DOI
https://doi.org/10.25004/IJPSDR.2017.090510References
2. Cotran RS, Kumar V, Collins T. Robbins pathologic basis of disease. 6th ed., Philadelphia: W. B. Saunders, 1999, pp. 932–933, 969–971, 1229.
3. Bailie GR. Acute renal failure. In Young LY, Koda-Kimble MA. (Eds.), applied therapeutics: The clinical use of drugs (6th edition). Vancouver, WA: Applied Therapeutics, 1996, pp. 29-6–29-17.
4. Hruska KA, Teitelbaum SL. Renal osteodystrophy. New England Journal of Medicine. 1995 Jul 20;333(3):166-75.
5. Couttenye MM, D'haese PC, Verschoren WJ, Behets GJ, Schrooten I, De Broe ME. Low bone turnover in patients with renal failure. Kidney International. 1999 Dec 31;56:S70-6.
6. Brenner BM, Lazarus JM. Chronic renal failure. In Wilson JD, Braunwald E, Isselbacher KJ, et al. (Eds.), Harrison’s principles of internal medicine. 12th ed., New York: McGraw-Hill, pp. 1150–1156.
7. Drüeke TB. Control of secondary hyperparathyroidism by vitamin D derivatives. American journal of kidney diseases. 2001 Jan 31;37(1):S58-61.
8. Tong EM, Nissenson AR. Erythropoietin and anemia. InSeminars in nephrology 2001 Mar 1 (Vol. 21, No. 2, pp. 190-203). Elsevier.
9. Besarab A, Levin A. Defining a renal anemia management period. American journal of kidney diseases. 2000 Dec 31;36(6):S13-23.
10. Eberst ME, Berkowitz LR. Hemostasis in renal disease: pathophysiology and management. The American journal of medicine. 1994 Feb 1;96(2):168-79.
11. Preston RA, Singer I, Epstein M. Renal parenchymal hypertension: current concepts of pathogenesis and management. Archives of internal medicine. 1996 Mar 25;156(6):602-11.
12. Al-Ahmad A, Sarnak MJ, Salem DN, Konstam MA. Cause and management of heart failure in patients with chronic renal disease. InSeminars in nephrology 2001 Jan 1 (Vol. 21, No. 1, pp. 3-12). Elsevier.
13. Gunukula SR, Spodick DH. Pericardial disease in renal patients. InSeminars in nephrology 2001 Jan 1 (Vol. 21, No. 1, pp. 52-56). Elsevier.
14. Rickus MA. Sexual dysfunction in the female ESRD patient. American Nephrology Nurses’ Association Journal. 1987; 14: 185–186.
15. Agodoa LY, Eggers PW. Renal replacement therapy in the United States: data from the United States renal data system. American journal of kidney diseases. 1995 Jan 1;25(1):119-33.
16. Daelemans RA, D'Haese PC, De Broe ME. Dialysis. In Seminars in nephrology 2001 Mar 1 (Vol. 21, No. 2, pp. 204-212). Elsevier.
17. Ramanathan V, Goral S, Helderman JH. (2001). Renal transplantation. Seminars in Nephrology 2001 Mar 1 (Vol. 21, No. 2, pp. 213-219). Elsevier.
18. Hanna JD, Krieg Jr RJ, Scheinman JI, Chan JC. Effects of uremia on growth in children. InSeminars in nephrology 1996 May (Vol. 16, No. 3, pp. 230-241).
19. Abitbol C, Chan JC, Trachtman H, Strauss J, Greifer I. Growth in children with moderate renal insufficiency: measurement, evaluation, and treatment. The Journal of pediatrics. 1996 Aug;129(2):s3-8.
20. Haffner D, Schaefer F, Nissel R, Wühl E, Tönshoff B, Mehls O. Effect of growth hormone treatment on the adult height of children with chronic renal failure. New England Journal of Medicine. 2000 Sep 28;343(13):923-30.
21. Hiramatsu M, Japanese Society for Elderly Patients on Peritoneal Dialysis. How to improve survival in geriatric peritoneal dialysis patients. Peritoneal Dialysis International. 2007 Jun 1;27(Supplement 2):S185-9.
22. Lin PC, Tsai CC, Hsu CC, Chen KT. Aging and comorbidity augment disease severity and requirements for treatment resources in older adults with lower extremity skin and soft tissue infection. Journal of the American Geriatrics Society. 2016 Jul 1;64(7):1515-6.
23. Lin PC, Liao YY, Hsu CC, Vong SC, Chen KT. Comorbidities and complications influence the diagnosis and management of geriatric supraglottitis. The American journal of emergency medicine. 2014 Nov 30;32(11):1334-8.
24. Castrale C, Evans D, Verger C, Fabre E, Aguilera D, Ryckelynck JP, Lobbedez T. Peritoneal dialysis in elderly patients: report from the French Peritoneal Dialysis Registry (RDPLF). Nephrology Dialysis Transplantation. 2009 Aug 7;25(1):255-62.
Published
Abstract Display: 483 
PDF Downloads: 188 How to Cite
Issue
Section
Copyright (c) 2017 A. Deevan Paul, C. Girish, T. N. Shilpa, Katta Manogna, A. Geetha Susmitha
This work is licensed under a Creative Commons Attribution 4.0 International License.
